Novoprotein (CliniSciences)

Novoprotein (CliniSciences)

Company Details

WebsiteLinkedIn

Status: Private

Employees: 101-250

Location:

Shanghai, China

Type:

sample

Technology:

sample

sample

sample

About: NOVOPROTEIN SCIENTIFIC , the mRNA reagent materials and recombinant proteins supplier from China. Novoprotein provides a one-stop solution of mRNA raw materials and services to support mRNA vaccines research and development. Our products include restriction enzymes, T7 RNA Polymerase, RNase inhibitor, Pyrophosphatase, DNaseI, Nucleotides, Vaccinia Capping Enzyme, mRNA 2´-O-Methyltransferase, Poly(A) Polymerase, RNase R, etc. The manufacturing processes are strictly controlled to ensure the products are animal-free and ampicillin-free. We guarantee the manufacturing and quality control comply with GMP regulation for tracking each step of the manufacturing process, including raw material sourcing. Novoprotein has developed more than ten thousand of recombinant proteins, like cytokines in cell therapy and organoid culture. We have researched and developed 7 technology platforms and 23 core technologies, including protein design and modification, protein production and quality control, protein application and evaluation. Novoprotein provides biomedical Industry customers with services from product development to technological innovation based on a comprehensive technology system and in-house innovative raw materials. James Pan - International Business Development email address: panyanzhi@novoprotein.com.cn
Unlock access to company contacts, hot leads, and drug pipelines.
Log in or create a free account now!
BiopharmIQ
Novoprotein (CliniSciences) | Active clinical trials on ClinicalTrials.gov

Active Clinical Trials Count | 0

No Active Trials Found On ClinicalTrials.gov.